MA51285A - Dérivés d'azaindole comme inhibiteurs de rho-kinase - Google Patents
Dérivés d'azaindole comme inhibiteurs de rho-kinaseInfo
- Publication number
- MA51285A MA51285A MA051285A MA51285A MA51285A MA 51285 A MA51285 A MA 51285A MA 051285 A MA051285 A MA 051285A MA 51285 A MA51285 A MA 51285A MA 51285 A MA51285 A MA 51285A
- Authority
- MA
- Morocco
- Prior art keywords
- rho
- kinase inhibitors
- azaindole derivatives
- azaindole
- derivatives
- Prior art date
Links
- BAXOFTOLAUCFNW-UHFFFAOYSA-N 1H-indazole Chemical class C1=CC=C2C=NNC2=C1 BAXOFTOLAUCFNW-UHFFFAOYSA-N 0.000 title 1
- 239000003590 rho kinase inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17208193 | 2017-12-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA51285A true MA51285A (fr) | 2021-04-28 |
Family
ID=60673855
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA051285A MA51285A (fr) | 2017-12-18 | 2018-12-14 | Dérivés d'azaindole comme inhibiteurs de rho-kinase |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US11332468B2 (fr) |
| EP (1) | EP3728248B1 (fr) |
| AR (1) | AR113947A1 (fr) |
| MA (1) | MA51285A (fr) |
| WO (1) | WO2019121406A1 (fr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3202146A1 (fr) | 2020-12-15 | 2022-06-23 | Fabio Rancati | Derives de dihydrofuropyridine en tant qu'inhibiteurs de la rho-kinase |
| MX2023005866A (es) | 2020-12-15 | 2023-06-05 | Chiesi Farm Spa | Derivados de dihidrofuropiridina como inhibidores de rho-cinasa. |
| EP4263546B1 (fr) | 2020-12-15 | 2025-07-02 | Chiesi Farmaceutici S.p.A. | Dérivés de dihydrofuropyridine en tant qu'inhibiteurs de rho-kinase |
| WO2023110700A1 (fr) | 2021-12-13 | 2023-06-22 | Chiesi Farmaceutici S.P.A. | Dérivés de dihydrofuropyridine utilisés comme inhibiteurs de la rho-kinase |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU9598601A (en) * | 2000-10-20 | 2002-04-29 | Eisai Co Ltd | Nitrogenous aromatic ring compounds |
| ES2273047T3 (es) | 2002-10-28 | 2007-05-01 | Bayer Healthcare Ag | Fenilaminopirimidinas sustituidas con heteroariloxi como inhibidores de rho-cinasa. |
| EP1756092A4 (fr) | 2004-06-17 | 2009-12-02 | Smithkline Beecham Corp | Inhibiteurs novateurs de protéines rho-kinases |
| WO2009079008A1 (fr) | 2007-12-19 | 2009-06-25 | Yangbo Feng | Benzopyranes et analogues utilisés comme inhibiteurs de la rho kinase |
| US20110166161A1 (en) | 2008-09-18 | 2011-07-07 | Astellas Pharma Inc. | Heterocyclic carboxamide compounds |
| PT2593452T (pt) | 2010-07-14 | 2017-04-24 | Novartis Ag | Compostos heterocíclicos agonistas do receptor ip |
| US20150225369A1 (en) * | 2012-08-29 | 2015-08-13 | Merck Patent Gmbh | Ddr2 inhibitors for the treatment of osteoarthritis |
| SMT201700317T1 (it) | 2013-01-29 | 2017-09-07 | Redx Pharma Plc | Derivati piridinici in qualità di inibitori rock teneri |
| TWI800498B (zh) | 2016-12-21 | 2023-05-01 | 義大利商吉斯藥品公司 | 作為Rho-激酶抑制劑之雙環二氫嘧啶-羧醯胺衍生物 |
| GEP20207202B (en) | 2017-01-30 | 2020-12-25 | Chiesi Farm Spa | Tyrosine amide derivatives as rho-kinase inhibitors |
-
2018
- 2018-12-14 US US16/954,977 patent/US11332468B2/en active Active
- 2018-12-14 WO PCT/EP2018/084998 patent/WO2019121406A1/fr not_active Ceased
- 2018-12-14 MA MA051285A patent/MA51285A/fr unknown
- 2018-12-14 EP EP18829278.3A patent/EP3728248B1/fr active Active
- 2018-12-14 AR ARP180103668A patent/AR113947A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3728248A1 (fr) | 2020-10-28 |
| US11332468B2 (en) | 2022-05-17 |
| US20200392133A1 (en) | 2020-12-17 |
| EP3728248B1 (fr) | 2022-02-02 |
| AR113947A1 (es) | 2020-07-01 |
| WO2019121406A1 (fr) | 2019-06-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA43753A (fr) | Dérivés 1-cyano-pyrrolidine comme inhibiteurs de dbu | |
| EP3478687A4 (fr) | Dérivés de pyrazolopyrimidine comme inhibiteurs de kinase | |
| MA45591A (fr) | Dérivés de 1,3-dihydroxy-phényle utiles comme immunomodulateurs | |
| EP3843714A4 (fr) | Inhibiteurs de cd73 | |
| IL268004B (en) | History of tyrosine amide as rho-kinase inhibitors | |
| ME03404B (fr) | Dérivés d'amides polycycliques comme inhibiteurs de la cdk9 | |
| MA41251A (fr) | Dérivés de thiéno[2,3-c]pyrrol-4-one comme inhibiteurs erk | |
| MA52413A (fr) | Inhibiteurs de cd73 | |
| LT3768674T (lt) | Aminopirimidino dariniai kaip ctps1 inhibitoriai | |
| MA45646A (fr) | Derives de benzimidazole comme des modulateurs de ror-gamma | |
| EP3337787A4 (fr) | Composés pyrazolo hétérocycliques condensés comme inhibiteurs d'erk | |
| MA40774A (fr) | Dérivés de diaryle-urée en tant qu'inhibiteurs de kinase p38 | |
| MA41140A (fr) | Dérivés de 2,4-dioxo-quinazoline-6-sulfonamide en tant qu'inhibiteurs de la parg | |
| DK3324977T3 (da) | Benzodiazepinderivater som rsv-inhibitorer | |
| EP3277381C0 (fr) | Dérivés de nitrobenzyle d'agents anticancéreux | |
| EP3416964A4 (fr) | Dérivés de carboxamide utiles en tant qu'inhibiteurs de rsk | |
| EP3322409A4 (fr) | Composés aza substitués comme inhibiteurs de l'irak-4 | |
| EP3787635A4 (fr) | Inhibiteurs de cd73 | |
| EP3999517A4 (fr) | Inhibiteurs de cd73 | |
| MA46981A (fr) | Dérivés de benzimidazole en tant qu'inhibiteurs de bromodomaine | |
| MA42597A (fr) | 2-amino-3-fluoro-3-(fluorométhyl)-6-méthyl-6-phényl-3,4,5,6-tétrahydropyridines comme inhibiteurs de bace1 | |
| EP3449001A4 (fr) | Inhibition de l'arnmi mir-22 par apt-110 | |
| EP3666770A4 (fr) | Nouveaux composés hétérocycliques comme inhibiteurs de cdk8/19 | |
| EP3302488A4 (fr) | Nouvelle utilisation de dérivés aryl-quinoléine comme inhibiteurs de l'imitation de facteurs vasculogènes | |
| EP3556758C0 (fr) | Dérivés de 1,2-dihydro-1,6-naphthyridin-2-one en tant qu'inhibiteurs de cdk4/6 |